Basic information Supplier
2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- Structure

2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)-

Chemical Properties

Density  1.45±0.1 g/cm3(Predicted)
pka 10.34±0.46(Predicted)
FDA UNII JP9CB4S87F

Preparation Products And Raw materials

2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)- Suppliers